PharmaNutra S.p.A. is an Italian pharmaceutical and nutraceutical company specializing in the research, development, production, and marketing of innovative nutritional supplements and medical devices. Headquartered in Pisa and founded in 2003, it is renowned for its leadership in iron-based supplements under the SiderAL® trademark, utilizing patented Sucrosomial® Technology to treat iron deficiencies and support immune health, with over 130 published scientific papers validating efficacy. The company also offers products for joint health via the Cetilar® brand, pregnancy nutrition, muscle and joint support, sports nutrition, ophthalmic care, and night rest solutions, alongside raw materials and bioimpedance analysis devices through its Akern subsidiary. With 118 employees, PharmaNutra distributes domestically via over 160 medical representatives to pharmacies and parapharmacies, and internationally to more than 60 countries through 40 partners, focusing on Europe, the Middle East, South America, and the Far East. Its commitment to proprietary raw materials, patents, and clinical data underscores its role in advancing healthcare and wellness solutions. Key figures include Chairman and CEO Andrea Lacorte and COO Carlo Volpi. PharmaNutra S.p.A. plays a vital part in the healthcare sector, particularly in specialty pharmaceuticals and nutraceuticals.